Home
Conditions
Triple Negative Breast Neoplasms

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies

Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer.

NCT06851299

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Triple-negative Breast Cancer, +5 more
Locations: Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Guangzhou, Guangdong, China

View Trial Details

Recruiting

Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC

NCT05192798

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China

View Trial Details

Recruiting

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

NCT05020860

Conditions: Breast Cancer, Breast Cancer Female, Breast Cancer Invasive, +14 more
Locations: Harris Health System - Smith Clinic Houston, Texas, United States

O'Quinn Medical Tower - McNair Campus - Dan L Duncan Comprehensive Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC

NCT06786026

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC

NCT06793332

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +12 more
Locations: Fudan University Shanghai Cancer center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer

NCT05475678

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Henan cancer hospital Zhengzhou, Henan, China

View Trial Details

Recruiting

A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer

NCT06492005

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

CtDNA Based MRD Testing for NAC Monitoring in TNBC

NCT06230185

Conditions: Breast Diseases, Breast Neoplasms, Minimal Residual Disease, +10 more
Locations: Arizona Oncology Tucson, Arizona, United States

University of Colorado Cancer Center Aurora, Colorado, United States

George Washington University Washington D.C., District of Columbia, United States

Mount Sinai Medical Center of Florida Miami Beach, Florida, United States

View all 14 locations

View Trial Details

Recruiting

All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial

NCT06636981

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study

NCT06538896

Conditions: Bone Metastases, Breast Diseases, Breast Neoplasms, +6 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Triple Negative Breast Neoplasms

Triple Negative Breast Neoplasms trial results

Related conditions